Whole Genome And Exome Sequencing Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact
Discover trends, market shifts, and competitive outlooks for the whole genome and exome sequencing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the Whole Genome And Exome Sequencing Market From 2025 To 2029?
The market size for whole genome and exome sequencing has seen a significant expansion in the past years. It is projected to rise from a value of $2.02 billion in 2024 to a worth of $2.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 24.8%. The impressive escalation during the historical period can be tied to factors such as the reduction in sequencing costs, the increase in genetic disorders, clinical usages, the growth of genomic data repositories, and advancements made in the field of bioinformatics.
The market size for whole genome and exome sequencing is anticipated to experience a massive increase in the upcoming years, reaching a size of $6.14 billion in 2029 with a compound annual growth rate (CAGR) of 24.9%. Factors predicted to contribute to this surge in the forecasted period are initiatives in population genomics, the growing need for precision medicine, advances in single-cell sequencing, the widening of non-invasive prenatal testing (NIPT), and its use in researching rare diseases. The key trends likely to be seen during this period are an increased clinical uptake, swift progress in the sequencing technologies, a rise in population-scale genomic studies, the incorporation of artificial intelligence (AI) and machine learning (ML), with a wider application in oncology.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp
What Are the Core Market Drivers Propelling Growth in the Whole Genome And Exome Sequencing Industry?
The increasing preference for personalized healthcare is set to bolster the expansion of the whole genome and exome sequencing industry in the forthcoming years. Customized medicine uses an approach that customizes healthcare choices and interventions to cater to personal attributes of each patient, including factors such as genetic make-up, environment, and lifestyle habits. Whole genome and exome sequencing comes into play in this field by giving an in-depth analysis of a patient’s genetic structure. This enables tailor-made medical decisions and interventions based on their distinctive genetic, environmental, and lifestyle factors. For example, in October 2022, the Personalized Medicine Coalition (PMC), an organization based in the U.S. that advocates the comprehension and uptake of customized medicine, projected that over 75,000 genetic test products and 300 tailored medicines would hit the market in 2022. Moreover, the Center for Drug Evaluation and Research (CDER) under the Food and Drug Administration sanctioned 37 new molecular entities (NMEs) in 2022. Additionally, approximately 34% of the 35 therapeutic NMEs, equating to 12 of them, have been categorized as personalized. As such, the surging popularity of customized medicine is fueling the expansion of the whole genome and exome sequencing industry.
How Is the Whole Genome And Exome Sequencing Market Segmented?
The whole genome and exome sequencing market covered in this report is segmented –
1) By Product Type: Kits, Instruments
2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications
4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits
2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp
Which Regions Are Driving the Next Phase of the Whole Genome And Exome Sequencing Market Growth?
North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Whole Genome And Exome Sequencing Industry?
Leading enterprises involved in the whole genome and exome sequencing markets are intensifying their efforts on developing superior technology-based solutions, like ultra-fast NGS (next-generation sequencing) analysis, to establish a competitive advantage. The ultra-fast NGS analysis, a state-of-the-art innovation, allows the processing of NGS data at an incredibly fast rate, thereby minimizing the time needed for genomic data analysis. For example, QIAGEN Digital Insights (QDI), a bioinformatics firm based in the US, introduced the ultra-fast NGS analysis platform in January 2023. The platform, costing $1 for processing an entire genome in 25 minutes via cloud computing, promotes not only efficiency and affordability, but also scalability. This technological advancement considerably boosts the speed and accessibility of genomic data analysis, making it crucial in the whole genome and exome sequencing market for facilitating swift decision-making and broader acceptance of personalized medicine.
View the full report here:
How Is the Whole Genome And Exome Sequencing Market Defined and What Are Its Core Parameters?
Whole genome sequencing (WGS) and exome sequencing (ES) are comprehensive genetic analysis techniques that involve determining the complete DNA sequence of an organism’s genome and sequencing the protein-coding regions of the genome. These analyses are used to sequence a person’s DNA for diagnosing genetic diseases and identifying cancer mutations.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
